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Primary hyperaldosteronism often results in resistant hypertension and hypokalemia,
which may lead to cardiovascular and cerebrovascular complications. Although surgery is
first line treatment for unilateral functioning aldosteronomas, minimally invasive thera-
pies may be first line for certain patients such as those who cannot tolerate surgery. We
present a case of transarterial embolization (TAE) of an aldosteronoma. The patient
presented with a cerebrovascular accident, and subsequently developed uncontrolled
hypertension, hypokalemia, and a myocardial infarction. Following TAE, potassium
returned to normal levels and blood pressure control was improved. There were no
postoperative complications. TAE thus may be a safe and effective alternative to surgery.
© 2016 Published by Elsevier Inc. on behalf of under copyright license from the University of
Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Primary hyperaldosteronism, also known as Conn syndrome,
is the excessive secretion of aldosterone from hyperfunc-
tioning adrenal gland tissue, resulting in intractable hyper-
tension and hypokalemia, which themselves may lead to
cerebrovascular disease, myocardial infarction, congestive
heart failure, and cardiac arrhythmias [1,2]. Most cases of
primary hyperaldosteronism are secondary to either anas a consultant at AngioD
(F.J. Gortes).
on behalf of under copyr
se (http://creativecommoadrenal adenoma or bilateral adrenal hyperplasia [1]. Surgical
resection is currently the standard treatment for adrenal
adenomas. However, percutaneous intervention may play a
role in treatment, particularly in those patients that may not
tolerate surgery. Here, we present a case of transarterial
embolization (TAE) with ethanol and embospheres of an
aldosteronoma in a patient with bilateral adrenal nodules and
discuss the presentation, assessment, and treatment of
functioning aldosterone tumors.ynamics Inc. All other authors have declared that no competing
ight license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Table 1 e Results of adrenal venous sampling.
Adrenal-to-adrenal aldosterone-to-cortisol ratio greater
than 4 indicates lateralization of disease, in this case of
the right adrenal gland. Adrenal-to-IVC cortisol greater
than 5 indicates correct placement of catheter in adrenal
vein. Contralateral adrenal aldosterone suppression is
noted.
Vein Aldosterone
(A), ng/dL
Cortisol (C),
mg/dL
A:C
ratio
Aldosterone
ratio
Right adrenal
vein
1279 483.4 2.64 22
Left adrenal
vein
51 408.5 0.12
IVC 73 61.7 1.18
IVC, inferior
vena cava.
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The patient was a 70-year-old Hispanic male with a past
medical history of an adrenal incidentaloma diagnosed 8
years ago, medically controlled hypertension, congestive
heart failure, and atrial fibrillation who presented to an
outside hospital for a cerebrovascular accident (CVA). Given
the patient's history of adrenal nodule, the CVA was thought
to be secondary to hypertension from a hyperfunctioning
adrenal nodule. A contrast computer tomography (CT) scan
was performed, which demonstrated a right nodulemeasured
at 2.2  2.5  2.4 cm and a left nodule measured at 3.3  2.2 
3.0 cm (Fig. 1). The right adrenal mass demonstrated approx-
imately 88 Hounsfield units (HU) on the arterial phase, 52 HU
in the portal venous phase, and 41 HU on the delayed phase,
with a 21% relative washout. The left adrenal mass measured
80 HU, 59 HU, and 37 HU in the arterial, portal venous, and
delayed phases, respectively, with a 37% relative washout.
Both nodules were thus considered to be of indeterminate
etiology based on CT criteria. The patient had refractory
hypertension and while undergoing physical therapy for the
CVA, his blood pressure suddenly rose to 280/110 mmHg. He
was subsequently admitted to our hospital, where his blood
pressure remained erratic and he developed hypokalemia
with a nadir of 2.8 mEq/L.
Endocrine evaluation revealed a plasma aldosterone of 25
ng/dL and a plasma renin activity level of 0.29 ng/mL$h. The
patient was scheduled for adrenal vein sampling, but he
developed a non-ST elevation myocardial infarction before
the procedure requiring emergent cardiac catheterization
with placement of a drug-eluting stent. Subsequently, adrenal
venous sampling was performed to elucidate the etiology of
his primary hyperaldosteronism. Results are summarized in
Table 1, which demonstrates right lateralization (aldosterone
ratio > 4:1) [3]. Surgical consultation was performed and the
patient was deemed a poor surgical candidate. InterventionalFig. 1 e Coronal CT slice demonstrating bilateral adrenal
nodules with the right nodule (arrow) measuring 2.2 £ 2.5
£ 2.4 cm.radiology was then consulted for a minimally invasive
alternative.
The patient was placed under general anesthesia and
intubated because of his labile blood pressures. After access-
ing the right common femoral artery, we cannulated the right
lateral adrenal artery using the standard technique. Arterio-
gram showed significant adenoma blush (Fig. 2). Super-
selective coil embolization of an anomalous phrenic branch
was then performed (Fig. 3). The catheterwas next pulled back
into the right lateral adrenal artery, and 3 mL of hydrated
alcohol was injected. At this time, the patient experienced
high blood pressures managed by the anesthesia team.
Roughly 1 mL of 300-500 mm embospheres was then injected
until stasis was achieved after which the proximal right
lateral adrenal artery was coiled. Postembolization contrast
injection demonstrated no tumor blush (Fig. 4). Right renal
artery angiogram showed no evidence of adrenal capsular
supply (Fig. 5). Right inferior phrenic artery angiography
showed perfusion to the superior lateral limb of the adrenal
gland without adenoma blush (Fig. 6).
The patient tolerated the procedure well and was
discharged 5 days later. Aldosterone levels normalized and
renin levels began to increase. His potassium stabilized at
borderline normal levels. As of 2-month follow-up, his blood
pressure has been well maintained on antihypertensive
medications.Discussion
Primary aldosteronism is the most common cause of
secondary hypertension, accounting for up to 15% of all
hypertension cases [4,5]. Conn syndrome, named after Dr
Jerome W. Conn who first described the disease, refers
specifically to primary hyperaldosteronism resulting from an
adrenal aldosteronoma. Although previously considered a
rare disease, it has been increasingly recognized as a sec-
ondary cause of hypertension that may improve, or resolve,
with adrenalectomy [5,6].
Clinical signsof thediseaseresult fromexcessivealdosterone
in the renal tubules and vascular injury [1]. Aldosterone hyper-
secretion induces excessive renal reabsorption of sodium at the
Fig. 2 e Arteriogram of the right lateral adrenal artery
showing significant adenoma blush (red arrow). Note the
presence of anomalous phrenic branch (blue arrows).
Fig. 4 e Arteriogram taken after transcatheter arterial
embolization with ethanol of the right lateral adrenal
artery demonstrating the absence of adenoma blush.
R a d i o l o g y C a s e R e p o r t s x x x ( 2 0 1 6 ) 1e5 3distal convoluted tubules [5]. Sodium retention promotes ab-
sorption of water, increasing extracellular fluid volume [1].
Aldosteronealsopromotessecretionofpotassiumandhydrogen
[5]. The combination of these factors results in hypertension,
hypernatremia, hypokalemia, andmetabolic alkalosis.Fig. 3 e Arteriogram following superselective microcoil
embolization of an anomalous phrenic branch originating
from the right adrenal gland. Note the coil placement
(yellow arrow).An increase in effective circulating volume suppresses the
release of renin, an enzyme which ultimately promotes the
formation of aldosterone. Decreased renin levels and an
elevated aldosterone-to-renin ratio are characteristic of the
disease. An aldosterone-to-renin ratio greater than 20-25 is
95% sensitive and 75% specific for the diagnosis of primary
aldosteronism [5].Fig. 5 e Right renal artery angiogram illustrating absence of
adrenal capsular supply. Note the coils in the anomalous
phrenic branch (top) and right lateral adrenal artery
(bottom).
Fig. 6 e Right inferior phrenic artery angiogram showing
perfusion of the superior lateral limb of the adrenal gland
(arrow) with the absence of adenoma blush.
R a d i o l o g y C a s e R e p o r t s x x x ( 2 0 1 6 ) 1e54Adrenal venous sampling is a useful diagnostic test, which
can demonstrate lateralization of primary aldosteronism,
particularly in cases of bilateral adrenal nodules. Bilateral
adrenal tumors occur in 6% of patients, and 49% of these pa-
tients have lateralization of the disease [1,5]. Aldosterone and
cortisol are measured bilaterally; adrenal-to-adrenal aldoste-
rone-to-cortisol ratios greater than 4 are indicative of lateral-
ization. Ratios less than 3 indicate idiopathic bilateral
hyperplasia, and ratios between 3 and 4 are indeterminate [5].
TAE with ethanol (TAEE) has been well documented in the
treatment of hepatic metastases, adrenal pheochromocy-
tomas, and renal cell carcinoma; however, its use in the
treatment of aldosteronomas is not well established in the
literature [1,2]. A study by Hokotate et al [2] found that 27 out
of 33 patients with Conn syndrome treated with TAEE expe-
rienced a decrease in blood pressure independent of sex, age,
duration of hypertension, location of the adenoma, the
number of embolized arteries, or the type of alcohol used.
Other minimally invasive alternatives to TAEE include
CT-guided percutaneous injection of ethanol or acetic acid
(CTEA) and CT-guided percutaneous radiofrequency ablation
(RFA). Adrenal hemorrhage has been reported with CT-guided
percutaneous injection of ethanol or acetic acid, mainly
because of the small size of adrenal tumors. There are no
studies describing adrenal hemorrhage after TAEE or RFA [7,8].
Much like TAEE, the use of RFA to treat primary hepatic tumors
and metastases has been well documented and accepted, but
few cases have been published on the treatment of adrenal
lesions [9]. However, recent studies have yielded promising
results for RFA. Szejnfeld et al performed RFA on 9 patients
with Conn syndrome, and 8 of the patients experienced a
significant decrease in aldosterone and blood pressure. Astudy by Yang et al [10] compared RFA to laparoscopic adre-
nalectomy for benign aldosterone-producing adenomas.
Patients treated with RFA experienced comparable normali-
zation in aldosterone and blood pressure with less post-
operative pain and shorter operative times. A potential
complication of RFA is thermal damage to the spleen and
surrounding vascular tissue. To date, there are no studies
comparing TAEE to RFA in the treatment of adrenal adenomas.
Surgery remains the primary treatment for unilateral
aldosteronomas, and recent improvements in laparoscopic
adrenalectomy have improved postsurgical outcomes. How-
ever, TAEE offers several advantages, which include a shorter
procedure time, reduced blood loss, and the option of using
minimal sedation with local anesthesia instead of general
anesthesia [1,2]. Patientswith labile blood pressures; however,
should be placed under general anesthesia. Lastly, success
rates between TAEE and surgery are comparable, at 82% for
TAEE vis-a-vis >90% for surgery [11,12].
Overall, our case of TAEE for the embolization of an
aldosteronoma was successful. There were no postprocedure
complications and the patient experienced complete resolu-
tion of symptoms. Although total embolization was not ach-
ieved with ethanol alone, embospheres were successfully
used to complete embolization. TAEE remains a viable and
effective alternative for patients who cannot undergo adre-
nalectomy. Moreover, our case suggests that TAEE in combi-
nation with microparticle embolization is more efficacious.
Future studies should explore the use of TAEE with supple-
mental embolization techniques and compare the efficacy
and safety of RFA to TAEE.r e f e r e n c e s
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